See the Unseen
Treat the Unseen… In-Situ
OncoLux is a MedTech company advancing a novel optical theranostics platform that combines multispectral fluorescence imaging and photodynamic therapy in a single integrated system to
“See and Treat” cancer during surgery.
The company’s preliminary clinical focus is on applying the technology intraoperatively during resection of advanced colorectal tumors to detect and eliminate residual disease to reduce disease recurrence after surgery.
The company applies advanced photonics and AI in this platform to achieve a new level of surgical visualization and targeted intraoperative therapy compatible with minimally invasive surgical procedures.
The multidisciplinary OncoLux team has decades of experience inthe photonics industry, with expertise in systems engineering and commercialization of new technology.
OncoLux is committed to pioneering the advancement and utility of optical theranostics for improving patient outcomes
IMAGE TO COME
IMAGE TO COME
Founders: Strong track record of execution
Our founders have a proven track record that sets us apart in the market. With extensive experience in delivering innovative solutions, they navigate challenges and seize opportunities, fostering trust and positioning us for sustainable growth.
ALAN KERSEY, CEO
Alan has been involved in the innovation and commercialization of optical instrumentation and biotech tools and systems through various start-ups in Connecticut for over 25 years.
TREVOR MACDOUGALL, VP & COO
Trevor has 35+ years of photonics industry experience in lead technical roles at 3M, CiDRA Corporation, Weatherford International, and is a co-founder of QRREX.
PAUL SANDERS, Advisor-Clinical Div.
Paul has 44 years of photonic industry experience in technical and senior management roles at 3M, JDS Uniphase, CiDRA Corporation, Weatherford International, and is a co-founder of QOREX.
DAVID FOURNIER, Advisor - Technology
David is an innovative and tenacious engineer with a broad skill set specializing in optical systems. He has a proven track record of developing groundbreaking technologies and recently served as VP of Systems Integration at CytoVeris Inc.
Advisors: Strong track record of execution
PETER TRAIANOU
Medical Devises
DAVID UFFER
Medical Devices
JASON PESTERFIELD
Corporate Strategy
LORI SWALM
Regulatory Advisor
Partners and Investors
Join us and be a part of our success.
At OncoLux, we are looking for individuals interested in shaping the future of surgery through innovative AI-powered imaging solutions.